Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02632656 · ClinicalTrials.gov registry record
Plasma ExtrAcellular RNAs and Biomarkers of Heart FaiLure During Decongestion: PEARL-HF Study
A clinical trial of Congestive Heart Failure, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT02632656 is a study of Congestive Heart Failure that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 400 participants, above the 322-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (24% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02632656, a study of Congestive Heart Failure, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective is to measure the association between extracellular RNA (ex-RNA) levels in plasma in patients receiving aggressive outpatient therapy for CHF with (1) cardiac remodeling and (2) cardiovascular events. The investigators will follow patients during standard medical therapy for CHF to assess changes in ex-RNA levels in the plasma, and how these are associated with cardiac remodeling (by cardiac imaging) and outcomes.
Conditions Studied
Interventions
- OTHER Monitoring on heart failure therapy
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2015-12 |
| Est. Completion | 2026-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02632656
The ClinicalTrials.gov registry entry for NCT02632656 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 322-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (24% higher). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Congestive Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Monitoring on heart failure therapy is the first listed.
NCT02632656 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02632656 about?
NCT02632656 is a clinical study titled "Plasma ExtrAcellular RNAs and Biomarkers of Heart FaiLure During Decongestion: PEARL-HF Study". The primary objective is to measure the association between extracellular RNA (ex-RNA) levels in plasma in patients receiving aggressive outpatient therapy for CHF with (1) cardiac remodeling and (2) cardiovascular events. The investigators will follow patients during standard medical therapy for CH...
What is the current status of trial NCT02632656?
This trial is currently active not recruiting. The enrollment target is 400 participants. The study started on 2015-12. Estimated completion is 2026-12-01.
What conditions does trial NCT02632656 study?
This clinical trial studies the following conditions: Congestive Heart Failure.
What interventions are being tested in trial NCT02632656?
The interventions under investigation include: Monitoring on heart failure therapy (OTHER).
Who is sponsoring clinical trial NCT02632656?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02632656 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congestive Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Palliative Care for People With HF
RECRUITING
-
Circulating Markers for Ischemic Heart Disease
RECRUITING
-
Stress and Congestive Heart Failure
RECRUITING · NA
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
-
Care Transitions App for Patients With Multiple Chronic Conditions
RECRUITING · NA
-
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.